March 22, 2004

NeoSurg Technologies, Inc. Receives ISO 13485 Certification
ISO 13485 Is A Major Milestone In Worldwide Commercialization Strategy

Houston, TX March 22, 2004 - NeoSurg Technologies, Inc., a leading developer of minimally invasive access products for laparoscopic surgery, today announced that it has received ISO 13485 Quality Certification from KEMA Medical based in the Netherlands, a quality management systems registrar.

The ISO 13485:2003 standards, released in July 2003 as the successor to ISO 13485:1996, is an internationally recognized quality management system standard developed by the International Organization for Standardization (ISO). To be certified to the standard, companies must implement a quality management system (QMS) embracing the activities of the company from staff training to taking the instruction from the customer, the design and development of products, the purchasing of materials and services and the delivery of the products and services, with all aspects of medical device, regulatory and industry requirements being addressed.

"NeoSurg Technologies, Inc. has always been committed to providing the highest levels of service excellence" stated Pete O’Heeron, NeoSurg’s CEO. "We are proud to be certified to ISO 13485. This demonstrates that our focus remains on quality, world-class performance, and continuously monitoring our business operations to ensure that we deliver on the promises we make to our customers, employees and vendors. By earning ISO 13485 certification, NeoSurg is demonstrating its commitment to quality.

"The NeoSurg team enthusiastically embraced and assisted in the development of the QMS. The management implementation team oversaw each stage of development and insured scheduled progress was timely, efficient and effective. We are very proud to have gained certification," stated Lisa Martinez, NeoSurg’s Quality Manager.

About the T2000 System
The T2000 System consists of a Reusable Trocar constructed of titanium and hard anodized aluminum for durability and reliability. The access tip is disposable which provides the surgeon with a consistently sharp and controlled penetration. A locking shielding mechanism is attached to the main trocar to guard the tip during insertion.

About NeoSurg Technologies
NeoSurg Technologies, Inc., based in Houston, Texas, is a privately held medical device company focused on bringing breakthrough products for minimally invasive surgery to market. These products are based on the Company’s patented technology, which allows the combination of disposable components with reusable components in a sophisticated and reliable system.

For more information on NeoSurg Technologies, Inc. visit the company Website at www.neosurg.com or contact:

Pete O’Heeron
President and Chief Executive Officer
(281) 461-6211
poheeron@neosurg.com

Certain statements made by the Company which are not historical facts may be considered forward-looking statements, including, and without limitation, statements as to trends, management’s beliefs, expectations and opinions, which are based upon a number of assumptions concerning future conditions that ultimately may prove to be inaccurate. Such forward-looking statements are subject to risks and uncertainties and may be affected by various factors, which may cause actual results to differ materially from those forward-looking statements.

.